Comparative Effects of Paraffin Bath Therapy and ESWT in Patients With De Quervain Tenosynovitis

November 28, 2022 updated by: Volkan Şah, Yuzuncu Yıl University

Comparative Effects of Paraffin Bath Therapy and Extracorporeal Shock Wave Therapy on Pain and Hand Functions in Patients With De Quervain Tenosynovitis

There is no study in the literature comparing both paraffin bath therapy and Extracorporeal Shock Wave Therapy (ESWT) in the treatment of patients with De Quervain Tenosynovitis. The aim of this study is performing this comparison.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Van, Turkey
        • Yuzuncu Yil University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being 18 years or older
  • Meeting De Quervain diagnostic criteria
  • Not having applied any physical therapy modality to the hand-wrist in the last 1 month
  • Not using pain medication in the last 1 month,
  • Not using local anesthetics or steroid injections on the hand-wrist in the last 3 months
  • Have received written consent to participate in the study, and have come to the last control at the 6th week.

Exclusion Criteria:

  • Neurological diseases (especially neuropathies),
  • Malignancy,
  • Rheumatological diseases
  • Pregnancy
  • History of hand/wrist fracture or surgery
  • Hand/wrist trauma in the last 1 month
  • Coagulation disorder diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Paraffin Bath Therapy
Paraffin bath therapy is a physical therapy method that can create a temperature increase of 7.5 °C in the joint capsule and 4.5 °C in the muscle.
Device named 'Fizyowax 1300' (Fizyomed, Turkey).
Active Comparator: Extracorporeal Shock Wave Therapy
Extracorporeal shock wave therapy (ESWT) is a noninvasive treatment that involves delivery of shock waves to injured soft tissue to reduce pain and promote healing.
Device named 'Elettronica Pagani,Italy' and will be used with radial probe.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: at baseline (before the treatment)
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
at baseline (before the treatment)
Visual Analogue Scale (VAS)
Time Frame: 2 weeks after baseline (at the end of treatment)
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
2 weeks after baseline (at the end of treatment)
Visual Analogue Scale (VAS)
Time Frame: 6 weeks after baseline (one month after the end of treatment)
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
6 weeks after baseline (one month after the end of treatment)
Duruöz Hand Index (DHI)
Time Frame: at baseline (before the treatment)
Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
at baseline (before the treatment)
Duruöz Hand Index (DHI)
Time Frame: 2 weeks after baseline (at the end of treatment)
Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
2 weeks after baseline (at the end of treatment)
Duruöz Hand Index (DHI)
Time Frame: 6 weeks after baseline (one month after the end of treatment)
Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
6 weeks after baseline (one month after the end of treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2022

Primary Completion (Actual)

September 5, 2022

Study Completion (Actual)

October 19, 2022

Study Registration Dates

First Submitted

June 14, 2022

First Submitted That Met QC Criteria

June 14, 2022

First Posted (Actual)

June 21, 2022

Study Record Updates

Last Update Posted (Actual)

November 29, 2022

Last Update Submitted That Met QC Criteria

November 28, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Van YYÜ School of Medicine

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on De Quervain Disease

Clinical Trials on Paraffin Bath Therapy

3
Subscribe